Search

Your search keyword '"Prasuhn, Michelle"' showing total 24 results
Start Over Author "Prasuhn, Michelle"
24 results on '"Prasuhn, Michelle"'

1. Treated Cases of Retinopathy of Prematurity in Germany: 10-Year Data from the Retina.net Retinopathy of Prematurity Registry

Author

Michalewicz, Emilia, Baumgarten, Sabine, Lohmann, Tibor, Walter, Peter, Breuß, Helge, Retzlaff, Annekatrin, Bödemann, Melanie, Liegl, Marian, El Moussaoui, Laila, Aisenbrey, Sabine, Saßmannshausen, Marlene, Liegl, Raffael, Engelmann, Katrin, Goldammer, Imke, Fleischer, Ulrike, Ander, Annika, Tietz, Martin, Wienigk, Anja, Li, Jeany Q., Krohne, Tim U., Guthoff, Rainer, Khamees, Ala, Kaya, Sema, Höhn, Thomas, Lohmeier, Klaus, Franzel, Julia, Busik, Valentina, Mais, Christine, Bemme, Sebastian, Khattab, Mohammed, Lauermann, Peer, Meyer, Yulia, Dieks, Jana Katharina, Bründer, Marie-Christine, Grundel, Bastian, Grundel, Milena, Paul, Sebastian, Stahl, Andreas, Tayar, Allam, Heckmann, Matthias, Bahlmann, Hagen, Linnemann, Knud, Skevas, Christos, Hagenau, Felix, Spitzer, Martin, Herden, Jonas, Gröber, Thomas, Haar, Melanie, Mester, Nils, Brockmann, Dorothee, Tode, Jan, Hufendiek, Karsten, Framme, Carsten, Bohnhorst, Bettina, Böhne, Carolin, Peter, Corinna, Pirr, Sabine, Brosig, Anton, Gniesmer, Stefanie, Grisanti, Salvatore, Lüken, Sabine, Piria, Roya, Prasuhn, Michelle, Ranjbar, Mahdy, Rommel, Felix, Schiemenz, Christian, Kakkassery, Vinodh, Heckert, Anni, Choritz, Lars, Glitz, Barbara, Eter, Nicole, Falkenau, Silvia, Gabel-Pfisterer, Ameli, Lindenberg, Ann-Sophie, Mathias, Altmann, Barth, Teresa, Benedikt, Blüml, Isabel, Oberacher-Velten, Patrick, Peters, Herbert, Jägle, Horst, Helbig, Stephan, Döring, Anette, Keller-Wackerbauer, Jochen, Kittel, Holger, Michel, Hugo, Segerer, Sven, Wellmann, Süsskind, Daniela, Partsch, Michael, Völker, Michael, Hagemann, Ulrike, Pfeil, Johanna M., Lagrèze, Wolf A., Lorenz, Birgit, and Breuss, Helge

Published
2024
Full Text
View/download PDF

2. Radiation-Induced DNA Damage in Uveal Melanoma Is Influenced by Dose Delivery and Chromosome 3 Status

Author

Tura, Aysegül, primary, Zhu, Yingda, additional, Vardanyan, Siranush, additional, Prasuhn, Michelle, additional, Kakkassery, Vinodh, additional, Lüke, Julia, additional, Merz, Hartmut, additional, Paulsen, Frank, additional, Rades, Dirk, additional, Cremers, Florian, additional, Bartz-Schmidt, Karl-Ulrich, additional, and Grisanti, Salvatore, additional

Published
2024
Full Text
View/download PDF

7. Treated Cases of Retinopathy of Prematurity in Germany

Author

Pfeil, Johanna M., Barth, Teresa, Lagrèze, Wolf A., Lorenz, Birgit, Hufendiek, Karsten, Liegl, Raffael, Breuss, Helge, Bemme, Sebastian, Aisenbrey, Sabine, Glitz, Barbara, Süsskind, Daniela, Gabel-Pfisterer, Ameli, Skevas, Christos, Krohne, Tim U., Kakkassery, Vinodh, Bründer, Marie-Christine, Engelmann, Katrin, Guthoff, Rainer, Walter, Peter, Choritz, Lars, Stahl, Andreas, Michalewicz, Emilia, Baumgarten, Sabine, Lohmann, Tibor, Walter, Peter, Breuß, Helge, Retzlaff, Annekatrin, Bödemann, Melanie, Liegl, Marian, El Moussaoui, Laila, Aisenbrey, Sabine, Saßmannshausen, Marlene, Liegl, Raffael, Engelmann, Katrin, Goldammer, Imke, Fleischer, Ulrike, Ander, Annika, Tietz, Martin, Wienigk, Anja, Li, Jeany Q., Krohne, Tim U., Guthoff, Rainer, Khamees, Ala, Kaya, Sema, Höhn, Thomas, Lohmeier, Klaus, Franzel, Julia, Busik, Valentina, Mais, Christine, Bemme, Sebastian, Khattab, Mohammed, Lauermann, Peer, Meyer, Yulia, Dieks, Jana Katharina, Bründer, Marie-Christine, Grundel, Bastian, Grundel, Milena, Paul, Sebastian, Stahl, Andreas, Tayar, Allam, Heckmann, Matthias, Bahlmann, Hagen, Linnemann, Knud, Skevas, Christos, Hagenau, Felix, Spitzer, Martin, Herden, Jonas, Gröber, Thomas, Haar, Melanie, Mester, Nils, Brockmann, Dorothee, Tode, Jan, Hufendiek, Karsten, Framme, Carsten, Bohnhorst, Bettina, Böhne, Carolin, Peter, Corinna, Pirr, Sabine, Brosig, Anton, Gniesmer, Stefanie, Grisanti, Salvatore, Lüken, Sabine, Piria, Roya, Prasuhn, Michelle, Ranjbar, Mahdy, Rommel, Felix, Schiemenz, Christian, Kakkassery, Vinodh, Heckert, Anni, Choritz, Lars, Glitz, Barbara, Eter, Nicole, Falkenau, Silvia, Gabel-Pfisterer, Ameli, Lindenberg, Ann-Sophie, Mathias, Altmann, Barth, Teresa, Benedikt, Blüml, Isabel, Oberacher-Velten, Patrick, Peters, Herbert, Jägle, Horst, Helbig, Stephan, Döring, Anette, Keller-Wackerbauer, Jochen, Kittel, Holger, Michel, Hugo, Segerer, Sven, Wellmann, Süsskind, Daniela, Partsch, Michael, Völker, Michael, and Hagemann, Ulrike

Abstract

To analyze changes in demographic parameters and retreatment patterns over a 10-year period in a clinical routine setting of infants with retinopathy of prematurity (ROP) requiring treatment documented in the German Retina.net ROP registry.

Published
2024
Full Text
View/download PDF

17. Association of Locus Coeruleus and Substantia Nigra Pathology With Cognitive and Motor Functions in Patients With Parkinson Disease

Author

Prasuhn, Jannik, primary, Prasuhn, Michelle, additional, Fellbrich, Anja, additional, Strautz, Robert, additional, Lemmer, Felicitas, additional, Dreischmeier, Shalida, additional, Kasten, Meike, additional, Münte, Thomas F., additional, Hanssen, Henrike, additional, Heldmann, Marcus, additional, and Brüggemann, Norbert, additional

Published
2021
Full Text
View/download PDF

23. Early REperfusion therapy with intravenous alteplase for recovery of VISION in acute central retinal artery occlusion (REVISION): Study protocol of a phase III trial.

Author

Poli S, Grohmann C, Wenzel DA, Poli K, Tünnerhoff J, Nedelmann M, Fiehler J, Burghaus I, Lehmann M, Glauch M, Schadwinkel HM, Kalmbach P, Zeller J, Peters T, Eschenfelder C, Agostini H, Campbell BC, Fischer MD, Sykora M, Mac Grory B, Feltgen N, Kowarik M, Seiffge D, Strbian D, Albrecht M, Alzureiqi MS, Auffarth G, Bäzner H, Behnke S, Berberich A, Bode F, Bohmann FO, Cheng B, Czihal M, Danyel LA, Dimopoulos S, Pinhal Ferreira de Pinho JD, Fries FN, Gamulescu MA, Gekeler F, Gomez-Exposito A, Gumbinger C, Guthoff R, Hattenbach LO, Kellert L, Khoramnia R, Kohnen T, Kürten D, Lackner B, Laible M, Lee JI, Leithner C, Liegl R, Lochner P, Mackert M, Mbroh J, Müller S, Nagel S, Prasuhn M, Purrucker J, Reich A, Mundiyanapurath S, Royl G, Salchow DJ, Schäfer JH, Schlachetzki F, Schmack I, Thomalla G, Tieck Fernandez MP, Wakili P, Walter P, Wolf A, Wolf M, Bartz-Schmidt KU, Schultheiss M, and Spitzer MS

Subjects
Humans, Double-Blind Method, Reperfusion methods, Treatment Outcome, Administration, Intravenous, Visual Acuity drug effects, Visual Acuity physiology, Male, Clinical Trials, Phase III as Topic, Female, Thrombolytic Therapy methods, Middle Aged, Retinal Artery Occlusion drug therapy, Tissue Plasminogen Activator therapeutic use, Tissue Plasminogen Activator administration & dosage, Fibrinolytic Agents therapeutic use, Fibrinolytic Agents administration & dosage, Recovery of Function drug effects
Abstract

Rationale: Meta-analyses of case series of non-arteritic central retinal artery occlusion (CRAO) indicate beneficial effects of intravenous thrombolysis when initiated early after symptom onset. Randomized data are lacking to address this question., Aims: The REperfusion therapy with intravenous alteplase for recovery of VISION in acute central retinal artery occlusion (REVISION) investigates intravenous alteplase within 4.5 h of monocular vision loss due to acute CRAO., Methods: This study is the randomized (1:1), double-blind, placebo-controlled, multicenter adaptive phase III trial., Study Outcomes: Primary outcome is functional recovery to normal or mildly impaired vision in the affected eye defined as best-corrected visual acuity of the Logarithm of the Minimum Angle of Resolution of 0.5 or less at 30 days (intention-to-treat analysis). Secondary efficacy outcomes include modified Rankin Score at 90 days and quality of life. Safety outcomes include symptomatic intracranial hemorrhage, major bleeding (International Society on Thrombosis and Haemostasis definition) and mortality. Exploratory analyses of optical coherence tomography/angiography, ultrasound and magnetic resonance imaging (MRI) biomarkers will be conducted., Sample Size: Using an adaptive design with interim analysis at 120 patients, up to 422 participants (211 per arm) would be needed for 80% power (one-sided alpha = 0.025) to detect a difference of 15%, assuming functional recovery rates of 10% in the placebo arm and 25% in the alteplase arm., Discussion: By enrolling patients within 4.5 h of CRAO onset, REVISION uses insights from meta-analyses of CRAO case series and randomized thrombolysis trials in acute ischemic stroke. Increased rates of early reperfusion and good neurological outcomes in stroke may translate to CRAO with its similar pathophysiology., Trial Registration: ClinicalTrials.gov: NCT04965038; EU Trial Number: 2023-507388-21-00., Competing Interests: Declaration of conflicting interestsThe author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Alteplase/placebo is provided by Boehringer Ingelheim at no costs. Boehringer Ingelheim was given opportunity to review the manuscript for medical/scientific accuracy and intellectual property considerations. The authors did not receive any payment related to trial/manuscript development.

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results